EUVIMEDEUVIMED entdecken
Crossref

A Mitochondria‐Targeted NIR‐II AIEgen Induced Pyroptosis for Enhanced Tumor Immunotherapy

Kaiwu Yu, Binglin Ye, Huang Yang, Xinxin Xu, Zhengwei Mao, Qinghua Zhang, Mei Tian, Haoke Zhang, Hong Zhang, Qinggang He iD

Advanced Healthcare Materials · 2023

DOI: 10.1002/adhm.202301693 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Kaiwu Yu und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, 310058, P. R. China. Hauptthemen laut MEDLINE: Nanoparticles, Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science Technology Department of Zhejiang Province, National Key R&D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer immunotherapy is a favorable strategy for facilitating anti‐tumor immunity, but it shows limited benefits in clinical practice owing to the immunosuppressive tumor microenvironment. Pyroptosis shows great immunostimulatory effect on tumor, whereas the lack of pyroptotic inducer with imaging property has restricted its progress in tumor theranostics. Herein, a mitochondria‐targeted aggregation‐induced emission (AIE) luminogen (TPA‐2TIN) with NIR‐II emission is designed for highly efficient induction of tumor cell pyroptosis. The fabricated TPA‐2TIN nanoparticles can be efficiently taken up by tumor cells and selectively accumulated in tumor for a long term observed by NIR‐II fluorescence imaging. More importantly, the TPA‐2TIN nanoparticles can effectively stimulate immune responses both in vitro and in vivo mediated by the mitochondrial dysfunctions and the subsequent activation of the pyroptotic pathway. Ultimately, the reversal of the immunosuppressive tumor microenvironment significantly enhances the immune checkpoint therapy. This study paves a new avenue for adjuvant immunotherapy of cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesNeoplasmsHumansPyroptosisImmunotherapyImmunizationMitochondriaTumor MicroenvironmentCell Line, Tumor

Stichwörter der Autor:innen

NIR-II imagingaggregation-induced emissionimmune checkpoint therapyimmunogenic cell deathpyroptosis

Autor:innen und Institutionen

  • College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, 310058, P. R. China.
  • Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, 310009, P. R. China.
  • MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, 310027, P. R. China.
  • Department of Nuclear Medicine and PET Center, The Second Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, P. R. China.

ORCID-Profile: Qinggang He

Förderung

  • National Natural Science Foundation of China
  • Science Technology Department of Zhejiang Province
  • National Key R&D Program of China
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Yu, K., Ye, B., Yang, H., Xu, X., Mao, Z., Zhang, Q., Tian, M., Zhang, H., Zhang, H., & He, Q. (2023). A Mitochondria‐Targeted NIR‐II AIEgen Induced Pyroptosis for Enhanced Tumor Immunotherapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202301693

Vancouver

Yu K, Ye B, Yang H, Xu X, Mao Z, Zhang Q, et al. A Mitochondria‐Targeted NIR‐II AIEgen Induced Pyroptosis for Enhanced Tumor Immunotherapy. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202301693

BibTeX
@article{Yu2023,
  author = {Yu, Kaiwu and Ye, Binglin and Yang, Huang and Xu, Xinxin and Mao, Zhengwei and Zhang, Qinghua and Tian, Mei and Zhang, Haoke and Zhang, Hong and He, Qinggang},
  title = {A Mitochondria‐Targeted NIR‐II AIEgen Induced Pyroptosis for Enhanced Tumor Immunotherapy},
  journal = {Advanced Healthcare Materials},
  year = {2023},
  doi = {10.1002/adhm.202301693}
}
Kostenlos starten →